COMMUNIQUÉS West-GlobeNewswire

Flexion Therapeutics to Report Second-Quarter 2018 Financial Results on August 7, 2018
30/07/2018
BURLINGTON, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2018 financial results after the close of the U.S. financial markets [...]
Retrophin Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
30/07/2018
SAN DIEGO, July 30, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the appointment of Noah L. Rosenberg, M.D., as chief medical officer, where he will oversee the clinical development of [...]
Kura Oncology to Report Second Quarter 2018 Financial Results
30/07/2018
SAN DIEGO, July 30, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
30/07/2018
RADNOR, Pa., July 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
SeaSpine Reports Second Quarter 2018 Financial Results
30/07/2018
Updates 2018 Financial Outlook CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of [...]
GenMark Diagnostics Reports Second Quarter 2018 Results
30/07/2018
CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
Editas Medicine to Host Conference Call Discussing Second Quarter 2018 Corporate Update and Results
30/07/2018
CAMBRIDGE, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday, August 6, 2018, at 5: [...]
Merit Medical Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
30/07/2018
SOUTH JORDAN, Utah, July 30, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and [...]
CytomX Therapeutics to Announce Second Quarter 2018 Financial Results
30/07/2018
SOUTH SAN FRANCISCO, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
athenahealth Reports Second Quarter Fiscal Year 2018 Results
30/07/2018
Company Achieves Strong Revenue and Earnings Growth; Updates Fiscal Year 2018 Financial Outlook WATERTOWN, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading [...]
Aeglea BioTherapeutics Announces Fall 2018 Medical Conference Schedule
30/07/2018
Company Will Provide New Interim Data for Pegzilarginase in Patients with Arginase 1 Deficiency Preclinical Efficacy Data of AEB4104 - a New Enzyme Approach - for the treatment of Homocystinuria Three-Conference [...]
New York Moves Closer to Legalizing Adult-Use, Game Changer for Cannabis Industry -- CFN Media
30/07/2018
SEATTLE, July 30, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
GlenBrook Health Center Named Great Place to Work
30/07/2018
CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- GlenBrook Health Center in Carlsbad, California, has been certified as a top workplace by the independent research and consulting firm Great Place to Work ®. Great [...]
Dynavax to Host Second Quarter 2018 Financial Results Conference Call
30/07/2018
Update on HEPLISAV-B® and Timing of Oncology Data BERKELEY, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will report financial results for the second [...]
FDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple Myeloma
30/07/2018
CAMBRIDGE, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
BrightGuard Installs Free Sunscreen Dispensers Throughout Los Angeles Beach Cities
30/07/2018
First-of-its-Kind Automated Sunscreen Dispenser Company Collaborates with UCLA Health and IMPACT Melanoma to Provide Free, High-Quality Sunscreen to Help Reduce LA’s Risk of Skin Cancer LOS ANGELES and NEWPORT BEACH, [...]
Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific Officer
30/07/2018
SEATTLE, July 30, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies for patients with hematologic malignancies and other critical diseases, today announced the [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
30/07/2018
Villepinte (France), le 30 juillet 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur [...]
Ossur Hf : Transactions in relation to share buyback program
30/07/2018
Announcement no. 48/2018 30 July 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]

Pages